Burning Rock Biotech Ltd
NASDAQ:BNR
Net Margin
Burning Rock Biotech Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Net Margin Comparison
Burning Rock Biotech Ltd Competitors
| Country | CN |
| Market Cap | 87.3m USD |
| Net Margin |
-122%
|
| Country | US |
| Market Cap | 295.4B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 144.2B USD |
| Net Margin |
24%
|
| Country | US |
| Market Cap | 102.5B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 97.4B USD |
| Net Margin |
30%
|
| Country | AU |
| Market Cap | 134.5B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 81.3B USD |
| Net Margin |
21%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 40.6B USD |
| Net Margin |
-69%
|
| Country | US |
| Market Cap | 29.3B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 36.9T KRW |
| Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Burning Rock Biotech Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Burning Rock Biotech Ltd's most recent financial statements, the company has Net Margin of -121.6%.
You don't have any saved screeners yet
